Recent Finacing
Recent Raise
Abri Science applies materials science to develop a therapeutic for phenylketonuria (PKU), commercializing university-licensed technology in collaboration with Early Charm Ventures and L2C Partners.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor